Stockholders’ Equity | 8. Stockholders’ Equity Common Stock and Equity Payable 2023 On January 31, 2023 a total of 545,012 On March 27, 2023 a total of 154,106 166,432 44,325 On March 27, 2023 a total of 9,651 10,423 2,757 On March 31, 2023 a total of $ 195,171 180,715 10,315 On March 31, 2023 a total of $ 10,196 9,441 542 During March of 2023, 15 3,587,487 1.00 3,587,487 1,792,745 2.00 577,000 63 0.3216 On June 30, 2023 a total of $ 196,148 181,620 On June 30, 2023 a total of $ 10,309 9,546 During August and September of 2023, 18 1,960,976 .82 1,608,000 3,921,952 .82 1,146,562 63 73 0.21 0.40 During the nine months ended September 30, 2023 a total of 163,757 shares were issued from stock payable related to related party accrued interest. As of the September 30, 2023 we had an equity payable balance of $ 100,862 2024 On June 30, 2024 a total of $ 445,379 1,093,267 On June 30, 2024 a total of $ 20,617 50,609 On September 30, 2024 a total of $ 225,136 964,593 On September 30, 2024 a total of $ 10,422 44,653 During the nine months ended September 30, 2024 2,516,394 1,355,081 As of the nine months ended September 30, 2024 we had an equity payable balance of $ 336,420 Stock-based Plans Stock Option Activity The following table summarizes stock option activity for the nine months ended September 30, 2024. Share Based Payment Arrangement Options Activity Options Weighted Average Exercise Price Weighted Average Remaining Contractual Term (Years) Outstanding at December 31, 2022 6,691,216 $ 1.19 5.86 Granted 2,678,500 $ — — Exercised — $ — — Forfeited/canceled (329,893 ) $ — — Expired (1,742,468 ) $ 0.90 7.28 Outstanding at December 31, 2023 7,297,355 $ — — Granted 260,000 $ — — Exercised — $ — — Forfeited/canceled (949,520 ) $ — — Expired (2,163,335 ) $ — — Outstanding at September 30, 2024 4,444,500 $ 0.92 7.72 2023 On May 11, 2023 the Company granted three 295,000 0.98 25 36 75.76 0.705183 208,029 On July 14, 2023 the Company granted one 1,000,000 0.85 25 36 74.55 0.5590 605,383 On July 17, 2023 the Company granted one 700,000 0.79 25 36 74.57 0.5713 396,441 On August 25, 2023 he Company granted four 650,000 0.65 25 36 64.81 0.4257 285,773 2024 On April 1, 2024, the Company granted two 250,000 0.502 25 36 73.63 0.212377 53,094 On August 14, 2024, the Company granted one 10,000 0.502 25 36 73.63 0.0724 724 Stock-Based Compensation Expense from Stock Options and Warrants The impact on our results of operations of recording stock-based compensation expense for the three and nine months ended September 30, 2024 and 2023 were as follows: Schedule of Stock-based Compensation Expense 2024 2023 2024 2023 Three Months Ended Nine Months Ended September 30, September 30, 2024 2023 2024 2023 General and administrative $ 3,261 $ 62,599 $ (35,842 ) $ 181,382 Sales and marketing 105,100 108,348 301,245 248,790 Engineering, research, and development 40,429 46,830 127,461 119,334 Total $ 148,790 $ 217,777 $ 392,864 $ 549,506 Valuation Assumptions The fair value of each stock option award was calculated on the date of the grant using the Black-Scholes option pricing model. The following weighted average assumptions were used for the nine months ended September 30, 2024 and 2023. Schedule of Stock Options Valuation Assumptions Nine Months Ended September 30, 2024 2023 Risk-free interest rate 4.69 % 3.99 % Expected life (years) 7.00 7.50 Expected dividend yield — % — % Expected volatility 73.63 % 73.47 % The risk-free interest rate assumption is based upon published interest rates appropriate for the expected life of our employee stock options. The expected life of the stock options represents the weighted-average period that the stock options are expected to remain outstanding and was determined based on the historical experience of similar awards, giving consideration to the contractual terms of the stock-based awards, vesting schedules and expectations of future employee behavior as influenced by changes to the terms of the Company’s stock-based awards. The dividend yield assumption is based on our history of not paying dividends and no future expectations of dividend payouts. The expected volatility in 2024 and 2023 is based on the historical publicly traded price of our common stock. Restricted stock units The following table summarizes restricted stock unit activity under our stock-based plans for the year ended December 31, 2023 and for the nine months ended September 30, 2024: Schedule of Restricted Stock Unit Activity Shares Outstanding at December 31, 2022 1,929,933 Awarded 414,104 Released (545,012 ) Canceled/forfeited/expired — Outstanding at December 31, 2023 1,799,025 Awarded 715,205 Released — Canceled/forfeited/expired — Outstanding at September 30, 2024 2,514,230 Expected to vest at September 30, 2024 2,514,230 Vested at September 30, 2024 2,514,230 Unvested at September 30, 2024 — Unrecognized expense at September 30, 2024 $ — 2023 On March 31, 2023, the Company granted four 61,342 65,002 1.05 On June 30, 2023, the Company granted four 80,160 65,003 0.81 On September 30, 2023, the company granted four 101,564 65,001 0.64 In the nine months ended September 30, 2023 the Company recorded $ 195,006 2024 On March 31, 2024 the company granted five 162,500 81,250 .50 On June 30,2024 the company granted five 187,210 81,249 .434 On September 30, 2024 the company granted five 365,495 81,250 .222 In the nine months ended September 30, 2024, the Company recorded $ 243,749 Stock Based Compensation from Restricted Stock The impact on our results of operations of recording stock-based compensation expense for restricted stock units for the three and nine months ended September 30, 2024 and 2023 was as follows: Schedule of Stock-based Compensation Expense from Restricted Stock 2024 2023 2024 2023 Three Months Ended Nine Months Ended September 30, September 30, 2024 2023 2024 2023 General and administrative $ 81,250 $ 65,001 $ 243,749 $ 195,006 Total $ 81,250 $ 65,001 $ 243,749 $ 195,006 As of September 30, 2024, there was no Warrants The following table summarizes investor warrants as of September 30, 2024 and the years ended December 31, 2023 and 2022: Schedule of Investor Warrants Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Term (Years) Outstanding at December 31, 2022 6,147,898 $ 1.45 2.27 Granted 9,563,787 $ — — Exercised (5,548,463 ) $ — — Canceled/forfeited/expired — $ — — Outstanding at December 31, 2023 10,163,222 $ 0.94 2.48 Granted 8,916,660 $ — — Exercised — $ — — Canceled/forfeited/expired — $ — — Outstanding at September 30, 2024 19,079,882 $ 0.77 2.13 2023 During March 2023, 15 3,587,487 1.00 3,557,487 3,921,952 2.00 577,000 63 0.3216 During August and September of 2023, 18 1,906,976 .82 3,557,487 1,793,745 .82 1,146,047 72 0.2922 2024 During the first quarter of 2024, one 3,291,664 .60 2,250,000 466,594 93 0.1418 During the second quarter of 2024, one 3,499,997 .60 2,100,000 371,242 91 0.1768 During the third quarter of 2024, one 2,124,999 .60 1,275,000 176,219 104 0.1403 |